IMPRINT is a network focusing on maternal and neonatal immunization, funded by the UK’s Global Challenges Research Fund (GCRF) which supports challenge-led interdisciplinary research and aims to strengthen capacity for research and innovation within the UK and in developing countries. IMPRINT is coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director Dr. Chrissie Jones (University of Southampton).
IMPRINT brings together people working with PASSION
IMPRINT aims to build a sustainable network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health and national and international policy makers, to tackle the challenges in the best use of vaccines in pregnancy and in newborns, and in the long term to improve maternal and newborn health.With well over 200 members from almost 50 countries that all share the same passion for maternal immunization, IMPRINT has quickly become a highly productive, multi-disciplinary and innovative network that is ready to make an impact.
Our board member Sonali Kochhar wrote an article on clinical trials during outbreaks that includes ethical considerations for the inclusion of pregnant women in vaccine trials.
UK Research and Innovation (UKRI) has published information regarding the impact of the COVID-19 pandemic on UKRI-supported research which includes IMPRINT grants and projects.
IMPRINT board member Beate Kampmann published a systematic review on the safety of administering live vaccines during pregnancy.